abstract |
The invention relates to indolinone compounds of formula (I), n n nwherein Y and R 1 to R 8 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation and the use thereof for preparing a pharmaceutical composition. |